S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
AMD   58.90 (+3.53%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
AMD   58.90 (+3.53%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
AMD   58.90 (+3.53%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
AMD   58.90 (+3.53%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
Log in

ETR:AFX - Carl Zeiss Meditec Stock Price, Forecast & News

€111.20
+1.60 (+1.46 %)
(As of 02/19/2020 04:00 PM ET)
Today's Range
€109.50
Now: €111.20
€112.40
50-Day Range
€108.80
MA: €115.25
€121.40
52-Week Range
€71.25
Now: €111.20
€122.10
Volume138,008 shs
Average Volume94,405 shs
Market Capitalization$9.95 billion
P/E Ratio58.65
Dividend Yield0.59%
BetaN/A
Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery. Read More…

Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+49-3641-2200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.51 billion
Cash Flow€0.26 per share
Book Value€15.64 per share

Profitability

Miscellaneous

Employees3,179
Market Cap$9.95 billion
Next Earnings Date5/11/2020 (Estimated)
OptionableNot Optionable

Receive AFX News and Ratings via Email

Sign-up to receive the latest news and ratings for AFX and its competitors with MarketBeat's FREE daily newsletter.


Carl Zeiss Meditec (ETR:AFX) Frequently Asked Questions

What is Carl Zeiss Meditec's stock symbol?

Carl Zeiss Meditec trades on the ETR under the ticker symbol "AFX."

When is Carl Zeiss Meditec's next earnings date?

Carl Zeiss Meditec is scheduled to release their next quarterly earnings announcement on Monday, May 11th 2020. View Earnings Estimates for Carl Zeiss Meditec.

What price target have analysts set for AFX?

8 brokers have issued twelve-month price objectives for Carl Zeiss Meditec's stock. Their forecasts range from €80.00 to €140.00. On average, they anticipate Carl Zeiss Meditec's stock price to reach €111.14 in the next year. This suggests that the stock has a possible downside of 0.1%. View Analyst Price Targets for Carl Zeiss Meditec.

What is the consensus analysts' recommendation for Carl Zeiss Meditec?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Carl Zeiss Meditec in the last year. There are currently 2 sell ratings, 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Carl Zeiss Meditec.

Has Carl Zeiss Meditec been receiving favorable news coverage?

News articles about AFX stock have trended neutral this week, InfoTrie reports. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Carl Zeiss Meditec earned a news sentiment score of 0.5 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the next few days. View News Stories for Carl Zeiss Meditec.

Who are some of Carl Zeiss Meditec's key competitors?

What other stocks do shareholders of Carl Zeiss Meditec own?

Who are Carl Zeiss Meditec's key executives?

Carl Zeiss Meditec's management team includes the folowing people:
  • Dr. Ludwin Monz, Pres, CEO & Chairman of Management Board (Age 56)
  • Mr. Justus Felix Wehmer, CFO & Member of the Management Board (Age 54)
  • Mr. Jan Willem de Cler, Head of Surgical Ophthalmology & Member of Management Board
  • Mr. Sebastian Frericks, Director of Investor Relations
  • Mr. Martin Wiechmann, Head of the Planetarium Bus. Unit

What is Carl Zeiss Meditec's stock price today?

One share of AFX stock can currently be purchased for approximately €111.20.

How big of a company is Carl Zeiss Meditec?

Carl Zeiss Meditec has a market capitalization of $9.95 billion and generates $1.51 billion in revenue each year. Carl Zeiss Meditec employs 3,179 workers across the globe.View Additional Information About Carl Zeiss Meditec.

What is Carl Zeiss Meditec's official website?

The official website for Carl Zeiss Meditec is http://www.zeiss.com/.

How can I contact Carl Zeiss Meditec?

Carl Zeiss Meditec's mailing address is Goeschwitzer Strasse 51-52, JENA, 07745, Germany. The company can be reached via phone at +49-3641-2200.


MarketBeat Community Rating for Carl Zeiss Meditec (ETR AFX)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  200 (Thanks for Voting!)
Underperform Votes:  234 (Thanks for Voting!)
Total Votes:  434
MarketBeat's community ratings are surveys of what our community members think about Carl Zeiss Meditec and other stocks. Vote "Outperform" if you believe AFX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AFX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/19/2020 by MarketBeat.com Staff

Featured Article: FTSE 100 Index

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel